To further characterize the effect of these kinase inhibitors in preventing the TDP-43 cell-to-cell transmission, we performed different studies using CM from severe AD cases treated independently with the TTBK1 inhibitor VNG1.47 or CK1 inhibitor IGS2.7. This evidence concerns the gene TTBK1 and Alzheimer disease.